VolitionRx Limited Files Current Report (8-K)

Ticker: VNRX · Form: 8-K · Filed: Aug 4, 2025 · CIK: 93314

Sentiment: neutral

Topics: material-agreement, corporate-action, filing

Related Tickers: VNRX

TL;DR

VNRX filed an 8-K on 8/1/25 for a material definitive agreement.

AI Summary

On August 1, 2025, VolitionRx Limited entered into a material definitive agreement. The company, previously known as Standard Capital Corp until August 12, 1999, is incorporated in Delaware and headquartered in Henderson, Nevada. This filing is a current report under the Securities Exchange Act of 1934.

Why It Matters

This 8-K filing indicates a significant event for VolitionRx Limited, potentially related to a new agreement that could impact its business operations and financial standing.

Risk Assessment

Risk Level: low — This filing is a standard disclosure of a material event and does not inherently present new risks.

Key Numbers

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by VolitionRx Limited on August 1, 2025?

The filing does not specify the details of the material definitive agreement, only that one was entered into on August 1, 2025.

What was VolitionRx Limited's former name and when did the name change occur?

VolitionRx Limited was formerly known as Standard Capital Corp, and the name change occurred on August 12, 1999.

In which state is VolitionRx Limited incorporated?

VolitionRx Limited is incorporated in Delaware.

What is the principal executive office address for VolitionRx Limited?

The principal executive office is located at 1489 West Warm Springs Road, Suite 110, Henderson, Nevada 89014.

What is the SEC file number for VolitionRx Limited?

The SEC file number for VolitionRx Limited is 001-36833.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding VOLITIONRX LTD (VNRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing